Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation
Authors
Keywords
-
Journal
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
Volume 52, Issue 3, Pages -
Publisher
FapUNIFESP (SciELO)
Online
2019-02-24
DOI
10.1590/1414-431x20188251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological modulation of radiation-induced oral mucosal complications
- (2018) S. Bockel et al. Cancer Radiotherapie
- Protective effect of dexamethasone on 5-FU-induced oral mucositis in hamsters
- (2017) Susana Barbosa Ribeiro et al. PLoS One
- New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
- (2017) Marika Cinausero et al. Frontiers in Pharmacology
- Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
- (2016) Ronaldo A. Ribeiro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement
- (2016) Michela Buglione et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention
- (2016) Naoto Okada et al. SUPPORTIVE CARE IN CANCER
- Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus
- (2015) Aurora Mirabile et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Metastatic Colorectal Cancer: Current State and Future Directions
- (2015) Marwan G. Fakih JOURNAL OF CLINICAL ONCOLOGY
- Azilsartan Reduced TNF-α and IL-1β Levels, Increased IL-10 Levels and Upregulated VEGF, FGF, KGF, and TGF-α in an Oral Mucositis Model
- (2015) Aurigena Antunes de Araújo et al. PLoS One
- MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
- (2014) Rajesh V. Lalla et al. CANCER
- The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
- (2014) D Hind et al. HEALTH TECHNOLOGY ASSESSMENT
- The hamster cheek pouch model for field cancerization studies
- (2014) Andrea Monti-Hughes et al. PERIODONTOLOGY 2000
- Effect of Amifostine in Head and Neck Cancer Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
- (2014) Jundong Gu et al. PLoS One
- Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia
- (2013) L. J. Radvansky et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Systematic review of amifostine for the management of oral mucositis in cancer patients
- (2012) Ourania Nicolatou-Galitis et al. SUPPORTIVE CARE IN CANCER
- Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation
- (2011) Roberto César P. Lima-Júnior et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role of Capsaicin-Sensitive Primary Afferent Neurons and Non-protein Sulphydryl Groups on Gastroprotective Effect of Amifostine Against Ethanol-Induced Gastric Damage in Rats
- (2010) Jerônimo Junqueira-Júnior et al. DIGESTIVE DISEASES AND SCIENCES
- New thoughts on the initiation of mucositis
- (2010) ST Sonis ORAL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started